334 research outputs found
A Probabilistic Choice Model of Multiple Items Selection
Conventional choice model of consumer behavior posits that buyers choose a single item or one brand at a time. However, there are many occasions that consumers pick up several items or a couple of brands at the same time to satisfy their own needs and/or to maximize their family\u27s utility. We can observe this kind of phenomena in the market of packaged consumer products such as tobacco, candy bar, beer, and soft drink. We construct a new probabilistic choice model of consumer behavior. In order to deal with such a situation that a consumer makes a simultaneous selection of multiple items from his consideration set of brands, we assume a two stage model of consumer choice behavior. At first stage, we suppose, a consumer makes a decision whether he buys a single brand or a mixed bundle of brands. Then he makes a decision of which brand (s) to be picked up and assigns the allocation number of multiple brands. We use a set of point-of-sale beer data scanned at a convenience store to estimate the model parameters. Our model is well fitted into the empirical data. Marketing implications and the possibilities of further extensions with our basic idea are provided
高血圧患者におけるアンジオテンシン II-レニンフィードバック機構に対するL/N型カルシウムチャネル拮抗薬の影響
Objectives. Cilnidipine, an L-/N-type calcium channel blocker (CCB), has unique organ-protective properties due to suppression of hyperactivity in the sympathetic nervous system and renin-angiotensin system (RAS). In this study, we hypothesized that cilnidipine might exert a renoprotective effect by suppressing the RAS.
Methods. A total of 25 hypertensive patients receiving a RAS inhibitor were randomly assigned to a cilnidipine (n = 12) or amlodipine (n = 13) group. The effects of cilnidipine on proteinuria and angiotensin II–renin feedback were assessed.
Results. After 6 months of treatment, both systolic and diastolic blood pressures were significantly reduced to a similar extent in both groups. The urine albumin-to-creatinine ratio was significantly lower in the cilnidipine group (p < 0.05) than in the amlodipine group. Amlodipine increased plasma angiotensin I and angiotensin II levels (p < 0.05), whereas cilnidipine did not. Interestingly, the cilnidipine group had a higher ratio of angiotensin-(1–7) (Ang-(1–7)) to angiotensin II in plasma than the amlodipine group (p < 0.05).
Conclusions. The L-/N-type CCB cilnidipine, but not amlodipine, decreased urinary albumin excretion in hypertensive patients. Cilnidipine also increased the ratio of Ang-(1–7) to angiotensin II in plasma, which might be one factor underlying its beneficial effects
Development of a high-resolution two-dimensional detector-based dose verification system for tumor-tracking irradiation in the CyberKnife system
We aim to evaluate the basic characteristics of SRS MapCHECK (SRSMC) for CyberKnife (CK) and establish a dose verification system using SRSMC for the tumor-tracking irradiation for CK. The field size and angular dependence of SRSMC were evaluated for basic characterization. The output factors (OPFs) and absolute doses measured by SRSMC were compared with those measured using microDiamond and microchamber detectors and those calculated by the treatment planning system (TPS). The angular dependence was evaluated by comparing the SRSMC with a microchamber. The tumor-tracking dose verification system consists of SRSMC and a moving platform. The doses measured using SRSMC were compared with the doses measured using a microchamber and radiochromic film. The OPFs and absolute doses of SRSMC were within ±3.0% error for almost all field sizes, and the angular dependence was within ±2.0% for all incidence angles. The absolute dose errors between SRSMC and TPS tended to increase when the field size was smaller than 10 mm. The absolute doses of the tumor-tracking irradiation measured using SRSMC and those measured using a microchamber agreed within 1.0%, and the gamma pass rates of SRSMC in comparison with those of the radiochromic film were greater than 95%. The basic characteristics of SRSMC for CK presented acceptable results for clinical use. The results of the tumor-tracking dose verification system realized using SRSMC were equivalent to those of conventional methods, and this system is expected to contribute toward improving the efficiency of quality control in many facilities
On-Orbit Demonstration of Innovative Multifunctional Membrane Structure for Ultra-Lightweight Solar Arrays and Array Antennas by 3U CubeSat OrigamiSat-1
The 3U CubeSat OrigamiSat-1’s deployable membrane structure is 1m-by-1m in size after deployment and is stowed in less than 1U CubeSat (10cm-by-10cm-by-8cm), including a hold-and-release mechanism. The major significance of the structural concept is that it allows the attachment of thin-film devices, such as thin-film solar cells or flexible substrates for antennas throughout the membrane. This was achieved by two features: (i) use of textile and (ii) invention of hybrid boom made of tubular carbon composite and metal convex tape. In addition, a visual membrane measurement system consisting of stereo cameras was developed. This paper describes the new technologies developed for this CubeSat
Dwarf Novae in the Shortest Orbital Period Regime: I. A New Short Period Dwarf Nova, OT J055717+683226
We report the observation of a new dwarf nova, OT J055717+683226, during its
first-ever recorded superoutburst in December 2006. Our observation shows that
this object is an SU UMa-type dwarf nova having a very short superhump period
of 76.67+/- 0.03 min (0.05324+/-0.00002 d). The next superoutburst was observed
in March 2008. The recurrence time of superoutbursts (supercycle) is, hence,
estimated to be ~480 d. The supercycle is much shorter than those of WZ
Sge-type dwarf novae having supercycles of >~ 10 yr, which are a major
population of dwarf novae in the shortest orbital period regime (<~85 min).
Using a hierarchical cluster analysis, we identified seven groups of dwarf
novae in the shortest orbital period regime. We identified a small group of
objects that have short supercycles, small outburst amplitudes, and large
superhump period excesses, compared with those of WZ Sge stars. OT
J055717+683226 probably belongs to this group.Comment: 14 pages, 11 figures, accepted for publication in PAS
Isolated gestational proteinuria preceding the diagnosis of preeclampsia : an observational study
Introduction. Some pregnant women develop significant proteinuria in the absence of hypertension. However, clinical significance of isolated gestational proteinuria (IGP) is not well understood. This study aimed to determine the prevalence of IGP in singleton pregnancies and the proportion of women with IGP who subsequently developed preeclampsia (IGP-PE) among all PE cases. Material and methods. This was an observational study of 6819 women with singleton pregnancies at 12 centers, including 938 women with at least once determination of protein-to-creatinine ratio (P/Cr). Significant proteinuria in pregnancy (SPIP) was defined as P/Cr (mg/mg) level >0.27. IGP was defined as SPIP in the absence of hypertension. Gestational hypertension (GH) preceding preeclampsia (GH-PE) was defined as preeclampsia (PE) in which GH preceded SPIP. Simultaneous PE (S-PE) was defined as PE in which both SPIP and hypertension occurred simultaneously. Results. IGP and PE were diagnosed in 130 (1.9%) and 158 (2.3%) of 6819 women, respectively. Of 130 women with IGP, 32 (25%) progressed to PE and accounted for 20% of all women with PE. Hence, women with IGP had a relative risk of 13.1 (95% CI; 9.2-18.5) for developing PE compared with those without IGP [25% (32/130) vs. 1.9% (126/6689)]. At diagnosis of SPIP, P/Cr levels already exceeded 1.0 more often in women with S-PE than in those with IGP-PE [67% (33/49) vs. 44% (14/32), respectively, p = 0.031]. Conclusions. IGP is a risk factor for PE, and IGP-PE accounts for a considerable proportion (20%) of all PE
Lp(a) on aortic valve calcification
Aortic valve calcification (AVC), which causes aortic stenosis (AS), is more common in elderly persons. Controlling for conventional risk variables did not, however, reduce the incidence of AS. Thus, residual risk factors of AS should be identified. We enrolled 513 patients who underwent coronary angiography with computed tomography because of suspicion of coronary artery disease (CAD) or ruling out of CAD before aortic valve replacement. Calcium volume was calculated with a commercially available application. Conventional and lipid-related risk factors including serum levels of Lp(a) were evaluated for all patients. Calcium volume and Lp(a) levels were significantly higher in patients who underwent aortic valve replacement than in those who did not. A single regression analysis showed that the calcium volume was positively associated with age and the Lp(a) levels and negatively associated with the estimated glomerular filtration rate. No statistical significance was observed for other risk factors, including oxidized low-density lipoprotein, omega-3 fatty acids levels. The multiple regression analysis revealed that age (P < 0.001), female sex (P < 0.05), Lp(a) (P < 0.01), and hemoglobin A1c (P < 0.01) were determinants of the calcium volume. The area under the curve in receiver operating characteristic analysis of Lp(a) for implementation of AVR was 0.65 at an Lp(a) cut-off level of 16 mg/dL. In conclusion, the serum Lp(a) level is a potent risk factor of AVC in patients with high risk of atherosclerosis
- …